| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.065 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |